Intuitive Surgical’s $1.28B Volume Ranks 65th in U.S. Trading as Stock Holds $600 Support Amid Cautious Positioning

On September 16, 2025, , , . equities. The stock’s performance reflects cautious investor positioning amid broader market consolidation ahead of key economic data releases.

Analysts highlighted limited catalysts for the medical device giant in recent sessions, with earnings estimates revisions and supply chain updates remaining neutral. Institutional buying activity was observed in early afternoon trading, though momentum failed to sustain into the closing bell. .

Back-test parameters require clarification to assess historical performance: Market scope must define whether to include all U.S. stocks or restrict to indices like S&P 1500. Pricing conventions need specification—execution at next day’s open versus same-day close. Portfolio aggregation methodology should confirm if equal-weighted returns are preferred over volume- or cap-weighted alternatives. These parameters directly influence the accuracy of historical strategy evaluations.

Once market universe, trade pricing rules, and aggregation method are finalized, a detailed data plan can be executed. The back-test will generate time-series returns, enabling calculation of total performance metrics, , and drawdown statistics as requested.